Allurion Technologies (ALUR) Other Non-Current Liabilities (2022 - 2026)
Allurion Technologies (ALUR) posted Other Non-Current Liabilities of $5.1 million for Q1 2026, up 1223.64% on a QoQ basis from $385000.0 in Q4 2025, and down 44.99% year-over-year from $9.3 million in Q1 2025.
Allurion Technologies (ALUR) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends
Allurion Technologies' Other Non-Current Liabilities history runs 5 years deep, the most recent figure standing at $5.1 million for Q1 2026.
- Quarterly Other Non-Current Liabilities fell 44.99% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (down 44.99% YoY) and the FY2025 annual result came in at $385000.0, up 2164.71% from the prior year.
- Other Non-Current Liabilities was $5.1 million for Q1 2026 at Allurion Technologies, up from $385000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $12.0 million in Q3 2023 and bottomed at $17000.0 in Q4 2024.
- A 5-year average of $5.4 million and a median of $5.4 million in 2024 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities surged 2904.5% — and 2024, when it tumbled 99.8%.
- Allurion Technologies' Other Non-Current Liabilities stood at $2.6 million in 2022, then jumped by 226.26% to $8.3 million in 2023, then tumbled by 99.8% to $17000.0 in 2024, then jumped by 2164.71% to $385000.0 in 2025, then jumped by 1223.64% to $5.1 million in 2026.
- Business Quant data shows ALUR's Other Non-Current Liabilities at $5.1 million in Q1 2026, $385000.0 in Q4 2025, and $816000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.10 Mn |
| Dec 31, 2025 | 385,000.00 |
| Sep 30, 2025 | 816,000.00 |
| Jun 30, 2025 | 926,000.00 |
| Mar 31, 2025 | 9.26 Mn |
| Dec 31, 2024 | 17,000.00 |
| Sep 30, 2024 | 9.87 Mn |
| Jun 30, 2024 | 5.61 Mn |
| Mar 31, 2024 | 9.80 Mn |
| Dec 31, 2023 | 8.32 Mn |
| Sep 30, 2023 | 12.02 Mn |
| Jun 30, 2023 | 10.88 Mn |
| Dec 31, 2022 | 2.55 Mn |
| Sep 30, 2022 | 400,000.00 |